Bank Of New York Mellon Corp Puma Biotechnology, Inc. Transaction History

Bank Of New York Mellon Corp

$541 Trillion
Q4 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$2.12 - $5.08 $122,966 - $294,655	58,003 New	58,003 $245,000
Q3 2022 Nov 14, 2022	SELL	$2.27 - $3.84 $4,583 - $7,752	-2,019 Reduced 6.3%	30,033 $71,000
Q2 2022 Aug 15, 2022	SELL	$1.64 - $3.3 $136,684 - $275,035	-83,344 Reduced 72.22%	32,052 $91,000
Q1 2022 May 11, 2022	SELL	$2.13 - $3.24 $1,491 - $2,268	-700 Reduced 0.6%	115,396 $332,000
Q4 2021 Feb 11, 2022	SELL	$2.85 - $6.58 $10,217 - $23,589	-3,585 Reduced 3.0%	116,096 $354,000
Q3 2021 Nov 12, 2021	BUY	$6.63 - $9.39 $45,833 - $64,913	6,913 Added 6.13%	119,681 $839,000
Q2 2021 Aug 11, 2021	SELL	$8.98 - $11.6 $206,872 - $267,229	-23,037 Reduced 16.96%	112,768 $1.04 Million
Q1 2021 May 13, 2021	SELL	$9.38 - $13.63 $46,234 - $67,182	-4,929 Reduced 3.5%	135,805 $1.32 Million
Q4 2020 Feb 09, 2021	SELL	$7.78 - $12.13 $63,772 - $99,429	-8,197 Reduced 5.5%	140,734 $1.44 Million
Q3 2020 Nov 12, 2020	SELL	$9.5 - $11.14 $5,880 - $6,895	-619 Reduced 0.41%	148,931 $1.5 Million
Q2 2020 Aug 12, 2020	SELL	$7.01 - $13.24 $147,539 - $278,662	-21,047 Reduced 12.34%	149,550 $1.56 Million
Q1 2020 May 06, 2020	SELL	$6.28 - $14.57 $17,960 - $41,670	-2,860 Reduced 1.65%	170,597 $1.44 Million
Q4 2019 Feb 14, 2020	BUY	$6.5 - $10.73 $35,009 - $57,791	5,386 Added 3.2%	173,457 $1.52 Million
Q3 2019 Nov 07, 2019	BUY	$8.75 - $12.85 $84,568 - $124,195	9,665 Added 6.1%	168,071 $1.81 Million
Q2 2019 Aug 12, 2019	SELL	$12.3 - $35.76 $249,726 - $726,035	-20,303 Reduced 11.36%	158,406 $2.01 Million
Q1 2019 May 14, 2019	BUY	$20.77 - $42.37 $305,173 - $622,542	14,693 Added 8.96%	178,709 $6.93 Million
Q4 2018 Feb 11, 2019	SELL	$20.07 - $46.7 $487,399 - $1.13 Million	-24,285 Reduced 12.9%	164,016 $3.34 Million
Q3 2018 Nov 09, 2018	BUY	$41.2 - $59.85 $251,938 - $365,982	6,115 Added 3.36%	188,301 $0
Q2 2018 Aug 06, 2018	SELL	$48.3 - $68.25 $33,906 - $47,911	-702 Reduced 0.38%	182,186 $10.8 Million
Q1 2018 May 15, 2018	BUY	$59.7 - $99.25 $383,393 - $637,383	6,422 Added 3.64%	182,888 $12.4 Million
Q4 2017 Feb 09, 2018	BUY	$93.85 - $132.45 $16.6 Million - $23.4 Million	176,466	176,466 $17.4 Million

Others Institutions Holding PBYI

# of Institutions

102

Shares Held

29.1M

Call Options Held

60.6K

Put Options Held

16.3K

Vanguard Group Inc Valley Forge, PA

3.64M
Shares

$10.5 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.57M
Shares

$10.4 Million
0.0% of portfolio
Frazier Life Sciences Management, L.P. Menlo Park, CA

3.06M
Shares

$8.88 Million
0.42% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

2.88M
Shares

$8.35 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

1.97M
Shares

$5.71 Million
0.02% of portfolio

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $132M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account